Genotypic-phenotypic variations in a series of 65 patients with familial amyloid polyneuropathy

Neurology

Volumn 51, Issue 3, 1998, Pages 708-714

  Plante Bordeneuve V ^b   Lalu, T ^c   Misrahi, M ^c   Reilly, M M ^a   Adams, D ^c   Lacroix, C ^c   Said, G ^c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b BICÊTRE HOSPITAL   (France)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE; PHENYLALANINE; SERINE;

AMINO ACID SUBSTITUTION; AMYLOID NEUROPATHY; ARTICLE; FAMILIAL DISEASE; GENETIC COUNSELING; GENETIC HETEROGENEITY; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; MOLECULAR GENETICS; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL;

EID: 0344074661     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.51.3.708     Document Type: Article

References (29)

1. Sousa A, Coelho T, Barros J, Sequeiros J. Genetic epidemiology of familial amyloidotic polyneuropathy (FAP)-type I in Povoa do Varzim and Vila do Conde (North of Portugal). Am J Med Genet 1995;60:512-521.
2. Andersson R. Familial amyloidosis with polyneuropathy. A clinical study based on patients living in northern Sweden. Acta Med Scand 1976;590(suppl):1-64.
3. Sakoda S, Suzuki T, Higa S, et al. Genetic studies of familial amyloid polyneuropathy in the Arao district of Japan: I. The genealogical survey. Clin Genet 1983;24:334-338.
4. Holt IJ, Harding AE, Middleton L, et al. Molecular genetics of amyloid neuropathy in Europe. Lancet 1989;1:524-526.
5. Sousa A, Andersson R, Drugge U, Holmgren G, Sandgren O. Familial amyloidotic polyneuropathy in Sweden: geographical distribution, age of onset, and prevalence. Hum Hered 1993; 43:288-294.
6. Said G, Ropert A, Faux N. Length-dependent degeneration of fibers in Portuguese amyloid polyneuropathy. A clinicopathological study. Neurology 1984;34:1025-1032.
7. Coutinho P, Martins Da Silva A, Lopes Lima J, Resende Barbosa A. Forty years of experience with type I amyloid polyneuropathy. Review of 483 cases. In: Glenner GG, Pinho P, Costa E, Falcao de Freitas A, eds. Amyloid and amyloidosis. Amsterdam: Excerpta Medica, 1980:88-98.
8. Sasaki H, Yoshioka N, Takagi Y, Sakaki Y. Structure of the chromosomal gene for human serum prealbumin. Gene 1985; 37:191-197.
9. Saraiva MJM. Transthyretin mutations in health and disease. Hum Mutat 1995;5:191-196.
10. Benson MD. Leptomeningeal amyloid and variant transthyretins. Am J Pathol 1996;148:351-354.
11. Satier F, Nichols WC, Benson MD. Diagnosis of familial amyloidotic polyneuropathy in France. Clin Genet 1990;38:469-473.
12. Benson MD, Turpin JC, Lucotte G, Zeldenrust S, LeChevalier B, Benson MD. A transthyretin variant (alanine 71) associated with familial amyloidotic polyneuropathy in a French family. J Med Genet 1993;30:120-122.
13. Benson MD, Julien J, Liepnieks J, Zeldenrust S, Benson MD. A transthyretin variant (alanine 49) associated with familial amyloidotic polyneuropathy in a French family. J Med Genet 1993;30:117-119.
14. Reilly MM, Adams D, Booth DR, et al. Transthyretin gene analysis in European patients with suspected familial amyloid polyneuropathy. Brain 1995;118:849-856.
15. Misrahi M, Planté-Bordeneuve V, Lalu T, et al. New transthyretin Ser 116 and Ser 91 variants associated with familial amyloidotic polyneuropathy. Hum Mutat 1998;12:71.
16. Yoshioka K, Furuya H, Sasaki H, Saraiva MJM, Costa PP, Sakaki Y. Haplotype analysis of familial amyloid polyneuropathy. Evidence for multiple origins of the Val→Met 30 mutation most common to the disease. Hum Genet 1989;82:9-13.
17. Reilly MM, Adams D, Davis MB, Said G, Harding AE. Haplotype analysis of French, British and other European patients with familial amyloid polyneuropathy (Met 30 and Tyr 77). J Neurol 1995;242:664-668.
18. Adams D, Samuel D, Goulon-Goeau C, et al. Evaluation of liver transplantation in a cohort of 29 patients with familial amyloid polyneuropathy. Neurology 1997;48(suppl 2):A88.
19. Reilly MM, Staunton H, Harding AE. Familial amyloid polyneuropathy (TTR Ala 60) in northwest Ireland: a clinical, genetic, and epidemiological study. J Neurol Neurosurg Psychiatry 1995;59:45-49.
20. Salvi F, Plasmati R, Michelucci R, et al. Clinical characterization of a new TTR variant in an Italian family: TTR Ala 49. In: Natvig J, Forre O, Husby G, et al, eds. Amyloid and amyloidosis. Dordrecht: Kluwer Academic Publishers, 1991:603-606.
21. Wallace MR, Dwulet FE, Williams EC, Conneally PM, Benson MD. Identification of a new hereditary amyloidosis prealbumin variant, Tyr-77, and detection of the gene by DNA analysis. J Clin Invest 1988;81:189-193.
22. Jacobson DR, Gertz MA, Buxbaum JN. Transthyretin Val 107, a new variant associated with familial cardiac and neuropathic amyloidosis. Hum Mutat 1994;3:399-401.
23. Almeida MR, Aoyama-Oishi N, Sakaki Y, et al. Haplotype analysis of common transthyretin mutations. Hum Genet 1995;96:350-354.
24. Fitch NJS, Akbari MT, Ramsden DB. An inherited non-amyloidogenic transthyretin variant, [Ser 6]-TTR, with increased thyroxin-binding affinity, characterized by DNA sequencing. J Endocrinol 1991;129:309-313.
25. Jacobson DR, Alves IL, Saraiva MJM, Thibodeau SN, Buxbaum JN. Transthyretin Ser 6 gene frequency in individuals without amyloidosis. Hum Genet 1995;95:308-312.
26. Harada T, Kito S, Shimoyama M, et al. Genetic and clinical studies of Japanese patients with familial amyloid polyneuropathy. Eur Neurol 1989;29:48-52.
27. Simmons Z, Blaivas M, Aguilera AJ, Feldman EL, Bromberg MB, Towfighi J. Low diagnostic yield of sural nerve biopsy in patients with peripheral neuropathy and primary amyloidosis. J Neurol Sci 1993;120:60-63.
28. Petersen RB, Goren H, Cohen M, et al. Transthyretin amyloidosis: a new mutation associated with dementia. Ann Neurol 1997;41:307-313.
29. Coelho T. Familial amyloid polyneuropathy: new developments in genetics and treatment. Curr Opin Neurol 1996;9: 355-359.